Going forward..., page-875

$8 on a bad day $12 if we play a little, 
the biggest problem with this takeover talk is if no offer comes, their seems to be more than a few on ere already banking on not being in by years end if not sooner, so the ol I didn’t get what I want TO they must shit bosses view will explode again 

GVHD was a proof of concept target, the 350 mill pa in nothing to asthma 

LM
they chose GVHD for easier pathway to trial, patients are already in real trouble so for science reason is a much easier pathway, now this has allowed us to progress multiple trials to phase 2, the payments attached whilst they may seem important, in a few months they will mean nothing, as the company stated many moons ago this is a proof of concept trial not our golden goose 
cheers